Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  IMMUNOASSAY INSTRUMENTS
A Global Strategic Business Report

This report analyzes the worldwide markets for Immunoassay Instruments in Millions of US$. The specific product segments analyzed are Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 85 companies including many key and niche players worldwide such as Abbott Laboratories, Beckman Coulter, Biomerieux, Bio-Rad Laboratories Inc., Roche Diagnostics, Siemens Healthcare Diagnostics, and Ortho-Clinical Diagnostics Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-3522  PAGES:    493
PRICE:    $3950  DATE:       April 2008
COMPANIES:  85  MARKET DATA TABLES:   155
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  IMMUNOASSAY INSTRUMENTS (Complete Report) Pages : 493   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS4$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Enzyme Immunoassay.....I-4
Fluorescence Immunoassay.....I-4
Chemiluminescence Immunoassay.....I-4
Radioimmunoassay.....I-4
Nephelometric Immunoassay .....I-4
  
II. EXECUTIVE SUMMARY86$2250
  1. Industry Overview.....II-14 $900  
   Outlook .....II-1
Market Promises Growth.....II-1
Industry Leading Players and Market Share.....II-1
1$100
   Table 1: Leading Players in Worldwide Immunoassay Instruments Market (2006-2007) - Percentage Breakdown by Value Sales for Abbott, Siemens Healthcare Diagnostics, Bayer, Roche, Biomerieux, Dade Behring, Diagnostic Products Corp, Beckman-Coulter, Ortho Clinical Diagnostics, and Others (includes corresponding graph/Chart).....II-21$350
   Table 2: Leading Diagnostics Companies Worldwide (2005) - Diagnostics Sales for Roche, Abbott, Bayer, Becton Dickinson, Beckman Coulter, Dade Behring, Ortho-Clinical Diagnostics, and bioMerieux (includes corresponding Graph/Chart).....II-3

Table 3: World Immunoassay Market by End-Use Industry (2004, 2005 & 2006): Percentage Breakdown by Value Sales for Clinical, Food and Environment Industries (includes corresponding Graph/Chart).....II-3
1$350
   Table 4: World Clinical Diagnostic Equipment Market by Geographic Region (2005 & 2006): Percentage Breakdown by Value Sales for US, Western Europe, Japan and Rest of World (includes corresponding Graph/Chart).....II-4
1$350
  2. Industry Trends.....II-54 $400  
   Instrument Rental - Name of the New Game.....II-5
Changing Scene for Immunodiagnostic Testing.....II-5
Hospital and Laboratory Consolidations Drive the Market for Analytical Laboratory
  Equipment.....II-5
Immunoassays - the Second-Largest Group of In Vitro Diagnostic Products.....II-5
1$100
   Immunoassay Techniques for Testing Environmental Samples.....II-6
Application of Immunoassays for Trace Methodology.....II-6
Laboratory Automation on Rise.....II-6
1$100
   Use of Immunoassays in Food Sciences and Quality Control.....II-7
Market for Adjunctive Therapies to Grow Fast.....II-7
Increasing Demand for Random Access Immunoanalyzers.....II-7
Advancement in Genetic Research Drives the Growth of this Market Segment.....II-7
Introduction of Portable Immunoassay Systems Energizes the Market.....II-7
1$100
   Technological Innovations Induces Growth.....II-8
Task-Targeted Automated Chemiluminescent Assays to Penetrate.....II-8
1$100
  3. Immunoassays - Combine Chemistry and Immunology.....II-94 $400  
   Definition and Description.....II-9
A Major Place in the Diagnostic Test Market.....II-9
1$100
   Turning the Hour Glass Back.....II-10
Shift Towards Point-of-Care Test Systems.....II-10
1$100
   Broad Application Range.....II-11
Labels - Necessary for Detection.....II-11
Customized Immunoassays.....II-11
Demerits of Immunoassays.....II-11
1$100
   Radioimmunoassay.....II-12
Non-Isotopic Immunoassays.....II-12
1$100
  4. Product Overview.....II-1320 $1000  
   Components of Immunoassays.....II-13
Signal Response.....II-13
Labeled Tracer.....II-13
Binder.....II-13
Buffer Matrix.....II-13
Incubation Conditions.....II-13
Separation Process.....II-13
1$100
   Standard Specimens.....II-14
Control Specimens.....II-14
Unknown Specimens.....II-14
Chemiluminescent Substrates - Growing Appeal.....II-14
Radioimmunoassay Analyzers, Gamma Counters.....II-14
1$100
   Fundamentals of Operation.....II-151$100
   Problems Involved.....II-161$100
   Enzyme Immunoassay Analyzers, Fluorescence Immunoassay Analyzers and
  Chemiluminescence’s Immunoassay Analyzers.....II-17
Enzyme Immunoassays.....II-17
1$100
   Automation Enabled.....II-18
Customization of Assays.....II-18
ELISA - A Flexible Enzyme Immunoassay Test..........II-18
1$100
   Constituents of ELISA.....II-19
Working.....II-19
Binding the Antigen and Antibody.....II-19
Conjugate Binding.....II-19
Evidence of Binding.....II-19
Fluorescence Immunoassay - Operating Principle.....II-19
1$100
   Light Sources.....II-20
Sample Cell.....II-20
Filters.....II-20
Detector.....II-20
1$100
   Time-Resolved Fluoroimmunoassay.....II-21
Chemiluminescence Immunoassay.....II-21
Types of Immunoassay Techniques.....II-21
Fluorescence Polarization Immunoassay.....II-21
1$100
   Radiative Energy Attenuation (REA).....II-22
Substrate-Labeled Fluorescence.....II-22
Enzyme Immunoassay with Fluorescence Detection.....II-22
1$100
   Solid-Phase Microsphere Immunoassay.....II-23
Microparticle Enzyme Immunoassay (MEIA).....II-23
Enzyme-Linked Fluorescence Immunoassay.....II-23
ELISA With Photometric Detection.....II-23
1$100
   Dry-Phase Techniques.....II-24
Sandwich Technique.....II-24
Competitive Binding.....II-24
Reversible Complex Formation.....II-24
1$100
   The Phase of Development.....II-25
Problems and Limitations.........II-25
1$100
   Purchase Considerations.....II-26
Cost Considerations.....II-26
Nephelometric Immunoassay.....II-26
1$100
   Nephelometry.....II-27
Types of Scatter.....II-27
Rayleigh Scatter.....II-27
Mie Scatter.....II-27
Rayleigh-Debye Scatter.....II-27
Key Components of Nephelometric Immunoassay Analyzers.....II-27
Light Sources.....II-27
1$100
   Detectors.....II-28
Automated Nephelometers.....II-28
1$100
   Modes of Operation.....II-29
Nephelometric Immunoassay Procedures.....II-29
Associated Problems.....II-29
1$100
   Purchase Considerations.....II-30
Test Menu.....II-30
Analytical Range.....II-30
1$100
   Linearity.....II-31
Specificity.....II-31
Precision.....II-31
Stability.....II-31
Carryover.....II-31
Downtime.....II-31
Upgrading / Interfacing.....II-31
Reagents.....II-31
Additional Features.....II-31
2$200
  5. Technology Developments.....II-332 $200  
   Rapid immunoassays for Diagnosis of Peptic Ulcers.....II-33
Latex Photometric Immunoassay Systems.....II-33
Gene Amplification Technology to Replace Immunoassays.....II-33
RAMP system from Response Biomedical.....II-33
Skye PharmaTech Develops S-100 Test.....II-33
1$100
   Full Disease Profiling with Dade’s Dimension RxL Clinical Chemistry System.....II-34
Bayer’s ADVIA - An Automation Platform.....II-34
Binax’s Rapid Flow-Thru Immunoassay System.....II-34
Abbott Launches LCx Technology Instrumentation.....II-34
1$100
  6. End-Use Markets for Immunoassay Instruments.....II-353 $300  
   Endocrine Testing Procedures.....II-35
Infectious Disease.....II-35
Blood Processing Market.....II-35
1$100
   Cancer Testing Markets.....II-36
Drugs of Abuse Testing Market.....II-36
Therapeutic Drug Monitoring.....II-36
1$100
   Immune Disease.....II-37
Blood Grouping and Typing......II-37
1$100
  7. Technology Posing a Threat to Immunoassay.....II-383 $300  
   Mature Technologies.....II-38
Cell Counting.....II-38
Clinical Chemistry.....II-38
Microbiology.....II-38
Emerging Technologies.....II-38
DNA Probes.....II-38
1$100
   Miniaturization and Microchip Fabrication.....II-39
Blood Glucose Testing.....II-39
Immunohistochemistry (IHC).....II-39
Non-Invasive Technology.....II-39
Image Analysis and Pattern Recognition.....II-39
1$100
   Rapidly Growing Molecular Diagnostics.....II-40
New Technologies.....II-40
High-Definition Cell Assay Technologies.....II-40
(1) Rapid, High-Definition Assays for Cellular Efficacy (RHACE).....II-40
(2) Single-Cell Analysis of Physiological Effects (SAPhE).....II-40
(3) Matrix Analysis of Genomically-Indexed Cells (MAGIC).....II-40
1$100
  8. In-Vitro Diagnostics - A Broad Discipline.....II-414 $800  
   Definition of In Vitro Diagnostics.....II-41
Importance of IVD.....II-41
World IVD Market.....II-41
1$100
   Table 5: World In-Vitro Diagnostics (IVD) Market by Product Segment (2005): Percentage Breakdown of Value Sales for Clinical Chemistry, Immunoassays, Microbiology & Virology, Nucleic Acid, Histology & Cytology and Others (includes corresponding Graph/Chart).....II-42

Table 6: World In-Vitro Diagnostics Products Market by Geographic Region (2005)- Percentage Breakdown by Values Sales for US, Canada, Europe, Japan and Rest of World (includes corresponding Graph/Chart).....II-42
Factors Influencing IVD Industry: On A Scale of 1-5.....II-42
1$350
   Technologies Used in IVD.....II-43
Major End-Use Markets.....II-43
Table 7: World In-Vitro Diagnostic Products Market by End-Use Segment (2005 & 2006E) – Percentage Breakdown by Value Sales for Hospitals and Commercial Labs, Decentralized and Ambulatory, and Patient Self-Testing (includes corresponding Graph/Chart).....II-43
Outlook .....II-43
1$350
   Competition.....II-44
Table 8: Leading Players in the Worldwide In Vitro Diagnostics (IVD) Market (2005) – Percentage Breakdown by Value Sales for Roche Diagnostics, Abbott Laboratories, Johnson & Johnson, Bayer Diagnostics, Beckman Coulter, Dade Behring, and Others (includes corresponding Graph/Chart).....II-44
1$350
  9. A Review of Recent Past.....II-451 $100  
   Bayer’s Acquisition of Chiron - The Turning Point.....II-45
1$100
  10. Product Launches.....II-469 $600  
   bioMérieux Introduces VIDAS® NT-proBNP.....II-46
Beckman Coulter Introduces UniCel DxC 880i Synchron® Access®.....II-46
Beckman Coulter Introduces UniCel® DxI 600.....II-46
bioMérieux Introduces VIDAS® B·R·A·H·M·S PCT® Assay.....II-46
Siemens Rolls Out ADVIA Centaur® Cyclosporine (CsA) Assay.....II-46
Ortho-Clinical Diagnostics Launches VITROS Troponin I ES Assay.....II-46
1$100
   Ortho-Clinical Diagnostics Introduces VITROS® Rubella IgG Assay.....II-47
Bayer Rolls Out ADVIA Centaur® XP System.....II-47
Bachem Releases Neuromedin S Immunoassays and Antibodies.....II-47
Roche Unveils The New Cobas 6000 Analyzer Series.....II-47
Ortho-Clinical Diagnostics Launches The VITROS NT-proBNP Assay.....II-47
Maxim Biotech Offers HIV-1 Urine EIA Kit.....II-47
1$100
   Assay Designs Rolls Out The Correlate™ Small Molecule ELISA Kits.....II-48
Oxis and BioCheck Mull to Launch Immunoassay Products for Oncology Research.....II-48
EDP Develops The CA1-18 EIA.....II-48
Instrumentation Laboratory’s Homocysteine Assay Gets FDA Nod.....II-48
Beckman Coulter Obtains FDA Clearance for Immunoassay System.....II-48
BioPAL to Develop Non-Invasive Diagnostic Assays.....II-48
1$100
   Mobious Genomics Develops A New Prototype for Immunoassay.....II-49
Immunoassay Market Witnesses A Unique Fluoroimmunoassay.....II-49
Development of A Tissue-Culture-Based Enzyme-Immunoassay.....II-49
Development of An Immunoassay to Measure Progesterone.....II-49
The Freedom EVOlyzer.....II-49
Development of An Immunoassay to Detect HIV Type 1 Infections.....II-49
Idexx Tests Tecan’s BSE Antigen EIA Test Kit.....II-49
1$100
   Bayer Introduces ADVIA Centaur® CP Immunoassay System.....II-50
Dade Behring Introduces N Latex CDT Assay in Europe.....II-50
DPC Launches Immunoassay Workcell.....II-50
Bayer Receives FDA Approval for Hepatitis B Assays.....II-50
Olympus Launches A New Immunoassay System.....II-50
LINCO Research Offers Multiple Immunoassays for Metabolic Diseases.....II-50
1$100
   Abbott Releases Automated Hepatitis C Virus Test for AxSYM® System.....II-51
Technical Solutions Develops Binax's Rapid Flow-Thru Immunoassay System.....II-51
EG&G Berthhold Introduces LB 953, an Automated Multi-Sample Luminometer.....II-51
Bayer Diagnostics Develops an Automated Assay for Measuring Oncoprotein
  HER-2/neu.....II-51
Sanofi Diagnostics Unveils Access Immunoassay System.....II-51
1$100
   Bayer Receives FDA Approval for Anti-HBc-IgM assay.....II-52
Abbott Launches Second Automated Test For Hepatitis A Virus.....II-52
Bio-Rad Laboratories Launches The BioPlex™ 2200.....II-52
Development of A microELISA System.....II-52
Development of A Dipstick Dye Immunoassay (DDIA).....II-52
TOSOH Bioscience Offers AIA-360 Random Access Immunoassay Analyzer (US).....II-52
1$100
   TOSOH Bioscience Unveils AIA®-1800 Automated Immunoassay Analyzer (US).....II-53
Beckman Introduces UniCel(tm).....II-53
Molecular Devices Introduces Threshold®.....II-53
Diagnostic Introduces IMMULITE 1000.....II-53
1$100
   Diagnostic Products Introduces Chemiluminescent IMMULITE 2000 AlaTOP.....II-54
1$100
  11. Recent Industry Activity.....II-5510 $700  
   Roche Acquires Ventana Medical Systems, Inc......II-55
Abbott Terminates Sale Agreement with GE.....II-55
Abbott Inks Agreement with Premier, Inc......II-55
Beckman Coulter Renews Agreement with MedAssets.....II-55
Beckman Coulter Extends Agreement Amerinet.....II-55
1$100
   Beckman Coulter Extends Partnership with Bio-Rad.....II-56
Siemens Acquires Dade Behring.....II-56
Roche Acquires BioVeris.....II-56
Siemens Healthcare Diagnostics Inks Agreement with Amerinet.....II-56
Siemens Healthcare Diagnostics Signs Agreement with Bio-Rad.....II-56
Siemens Medical Solutions USA Sets Up Siemens Healthcare Diagnostics.....II-56
1$100
   Siemens Medical Solutions Acquires Diagnostic Products Corporation.....II-57
Inverness Medical Innovations Acquires Immunoassay Business of ACON Laboratories
  Inc.....II-57
Omni USA Acquires Brendan Technologies Inc.....II-57
China Medical Technologies Develops Two HIV Diagnostic Reagents.....II-57
Nanogen Acquires Immunoassay Test Business of Spectral Diagnostics.....II-57
OXIS International Acquires BioCheck.....II-57
1$100
   Beckman Coulter Acquires Diagnostic Systems Laboratories.....II-58
Magellan acquires TekCel.....II-58
Abbott and IHC Sign A Contract.....II-58
Abbott Partners with Axis-Shield.....II-58
Gen-Probe Enters into an Agreement with Qualigen.....II-58
1$100
   Beckman Coulter Signs Multiple Agreements with Premier.....II-59
Bio-Rad Acquires MJ GeneWorks (US).....II-59
Roche Acquires Igen.....II-59
Bio-Rad and Enzon Signs Marketing Agreement (US).....II-59
Bayer HealthCare Enters into a Two-Year Agreement with Community of Sant’Egidio
  (US).....II-59
Roche Diagnostics Provides a Non-Exclusive License to Diagnostic Products (US).....II-59
1$100
   IDS Enters into an Licensing Agreement with Beckman Coulter (UK).....II-60
Gyros AB Signs a Licensing and Development Agreement with Fujirebio (Japan).....II-60
DPC Enters into a Distribution Agreement with Thermo Electron (US).....II-60
DPC and Premier Signs Laboratory Supply Agreement (US).....II-60
Procyon to Develop PSP94 Serum-Based Immunoassay.....II-60
1$100
   Roche Wins AmeriNet® Contract.....II-61
Beckman Enters into an Agreement with R&D Systems.....II-61
Beckman Coulter Enters into an Agreement with Bio-Rad (US).....II-61
Roche Receives FDA Approval for Elecsys®.....II-61
Bio Rad’s Immuno Assay Link up with Beckman Coulter Jumpstarts US Market Entry.....II-61
1$100
   IVAX Acquires Sigma’s Enzyme Immunoassay Product Line.....II-62
FDA Clears Bayer Diagnostics’ Complexed PSA (cPSA) Assay .....II-62
Spectral Diagnostics Inc. Licenses Troponin I Technology to Abbott
  Laboratories.....II-62
Dade Behring Obtains a Non-Exclusive License from Roche Diagnostics (US).....II-62
1$100
   Ecstasy Test Receives Clearance.....II-63
Tosoh Medics Launches Tumor Marker for Breast Cancer.....II-63
Tosoh Medics Launches Short Time Estradiol and Progesterone.....II-63
FDA clears Quantitative Immunoassay Testing System of Qualigen.....II-63
AIA-600 II Cleared for Early Detection of Prostate Cancer.....II-63
2$200
  12. Focus on Select Market Participants.....II-654 $400  
   Abbott Laboratories (US).....II-65
Beckman Coulter Inc. (US).....II-65
1$100
   bioMérieux (France).....II-66
Bio-Rad Laboratories Inc. (US).....II-66
1$100
   Roche Diagnostics (US).....II-67
Siemens Healthcare Diagnostics (US).....II-67
Ortho-Clinical Diagnostics Inc (US).....II-67
2$200
  13. Global Market Perspective.....II-69   
   Table 9: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-691$350
   Table 10: World Long Term Projections for Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-701$350
   Table 11: World 10-Year Perspective for Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-711$350
   Immunoassay Systems Market by Product Segment.....II-72
Table 12: World Recent Past, Current & Future Analysis for Enzyme Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-72
1$350
   Table 13: World Long Term Projections for Enzyme Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-731$350
   Table 14: World 10-Year Perspective for Enzyme Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-741$350
   Table 15: World Recent Past, Current & Future Analysis for Fluorescence Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-751$350
   Table 16: World Long Term Projections for Fluorescence Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-761$350
   Table 17: World 10-Year Perspective for Fluorescence Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-771$350
   Table 18: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-781$350
   Table 19: World Long Term Projections for Chemiluminescence Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-791$350
   Table 20: World 10-Year Perspective for Chemiluminescence Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-801$350
   Table 21: World Recent Past, Current & Future Analysis for Radio Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-811$350
   Table 22: World Long Term Projections for Radio Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-821$350
   Table 23: World 10-Year Perspective for Radio Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-831$350
   Table 24: World Recent Past, Current & Future Analysis for Nephelometric Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-841$350
   Table 25: World Long Term Projections for Nephelometric Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-851$350
   Table 26: World 10-Year Perspective for Nephelometric Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-861$350
III. MARKET74$1950
  1. The United States.....III-126 $1250  
   A. Market Analysis.....III-1
Market Overview.....III-1
Leading Players.....III-1
Table 27: Leading Players in the US Immunoassay Instruments Market (2005, 2006 & 2007): Percentage Breakdown by Value Sales for Abbott, Siemens Healthcare Diagnostics, Beckman Coulter, Bayer, Dade Behring, Roche, Ortho Diagnostics, Diagnostic Products Corporation and Others (includes corresponding Graph/Chart).....III-1
1$200
   Table 28: Leading Players in the US Immunoassay Products (BNP and NT-proBNP) Market (2005)- Percentage Breakdown by Value Sales for Abbott, Bayer, Beckman Coulter, Roche, Dade Behring, DPC and Others (includes corresponding Graph/Chart).....III-2
US Market for Clinical Laboratory Instruments.....III-2
Trends in the Marketplace.....III-2
1$200
   Laboratory Consolidation and Automation on a Rise.....III-3
Product Launches.....III-3
7$525
   Strategic Corporate Developments.....III-1011$525
   Focus on Select Players.....III-213$225
   B. Market Analytics.....III-24
Table 29: US Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-24
1$200
   Table 30: US Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-251$200
   Table 31: US 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-26
1$200
  2. Canada.....III-273 $425  
   A. Market Analysis.....III-27
Market Overview.....III-27
Strategic Corporate Development.....III-27
B. Market Analytics .....III-27
Table 32: Canadian Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-27
1$200
   Table 33: Canadian Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-281$200
   Table 34: Canadian 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-29
1$200
  3. Japan.....III-306 $625  
   A. Market Analysis.....III-30
Market Highlights.....III-30
Japanese Medical Instrument Market.....III-30
Product Launches.....III-30
1$75
   Strategic Corporate Developments.....III-311$75
   Focus on Key Players.....III-321$75
   B. Market Analytics.....III-33
Table 35: Japanese Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-33
1$200
   Table 36: Japanese Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-341$200
   Table 37: Japanese 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-35
1$200
  4. Europe.....III-368 $875  
   A. Market Analysis.....III-36
Table 38: European IVD Market, 2006: Leading Players by Market Share for Roche, Dade, Abbott, Beckman, Bayer, bioMerieux , OCD and Others (includes corresponding Graph/Chart).....III-36
Immunodiagnostic Products Market.....III-36
1$200
   Trends in Immunodiagnostic Market.....III-37
Outlook.....III-37
European Market for Immunoassay Systems.....III-37
1$75
   Factors Influencing European on-Isotopic Immunoassay Systems Market: (On a Scale of 1
  to 10).....III-38
Applications.....III-38
Decreasing Profitability.....III-38
Market Scenario.....III-38
1$75
   B. Market Analytics.....III-39
Table 39: European Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region – France, Germany, Italy, the UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-39
1$200
   Table 40: European Long Term Projections for Immunoassay Systems by Geographic Region – France, Germany, Italy, the UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-401$200
   Table 41: European Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-411$200
   Table 42: European Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-421$200
   Table 43: European 10-Year Perspective for Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, the UK and Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-43

Table 44: European 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-43
1$200
  4a. France.....III-444 $450  
   A. Market Analysis.....III-44
Market Trends.....III-44
bioMérieux – A Key Player.....III-44
1$75
   B. Market Analytics.....III-45
Table 45: French Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-45
1$200
   Table 46: French Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-461$200
   Table 47: French 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-47
1$200
  4b. Germany.....III-485 $625  
   A. Market Analysis.....III-48
Market Trends.....III-48
Table 48: Penetration of In Vitro Diagnostics in Different User Groups in Germany (2006E): Percentage Breakdown for Hospitals, OTC/ Pharmacies, Private Laboratories and General Practitioners, Non-human Medicine, Blood Banks, Research Institutes, and Others (includes corresponding Graph/Chart).....III-48
1$200
   Product Launches.....III-491$75
   Strategic Corporate Developments: Historic.....III-50
B. Market Analytics.....III-50
Table 49: German Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-50
1$200
   Table 50: German Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-511$200
   Table 51: German 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-52
1$200
  4c. Italy.....III-533 $425  
   Market Analysis.....III-53
Market Overview.....III-53
Table 52: Italian Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-53
1$200
   Table 53: Italian Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-541$200
   Table 54: Italian 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-55
1$200
  4d. The United Kingdom.....III-564 $450  
   A. Market Analysis.....III-56
Market Highlights.....III-56
Strategic Corporate Development.....III-56
IDS – A Key Player in the UK.....III-56
1$75
   B. Market Analytics.....III-57
Table 55: UK Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-57
1$200
   Table 56: UK Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-581$200
   Table 57: UK 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-59
1$200
  4e. Rest of Europe.....III-603 $425  
   A. Market Analysis.....III-60
Market Trends.....III-60
B. Market Analytics.....III-60
Table 58: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-60
1$200
   Table 59: Rest of Europe Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-611$200
   Table 60: Rest of Europe 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-62
1$200
  5. Asia-Pacific.....III-639 $725  
   A. Market Analysis.....III-63
Market Highlights.....III-63
Growing In-Vitro Diagnostics (IVD) Market Fuels the Demand for Immunoassay
  Instruments in Asia.....III-63
Review of Select Asian Markets.....III-63
China.....III-63
Chinese Market for Diagnostic Products.....III-63
1$75
   Influencing Forces.....III-64
Market Characteristics.....III-64
Competitive Analysis.....III-64
Strategies.....III-64
1$75
   End-User Analysis.....III-65
Hospitals.....III-65
Laboratories.....III-65
General Population.....III-65
Difficulties Posed by the Market.....III-65
1$75
   Distribution Channels.....III-66
Malaysia.....III-66
Health Care Services.....III-66
Singapore.....III-66
Clinical Laboratory Equipment Market in Singapore.....III-66
1$75
   Market Characteristics.....III-67
Imports Scene.....III-67
Distribution.....III-67
End-User Analysis.....III-67
1$75
   Strategic Corporate Development.....III-681$75
   B. Market Analytics.....III-69
Table 61: Asia Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-69
1$200
   Table 62: Asia Pacific Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-701$200
   Table 63: Asia Pacific 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-71
1$200
  6. Latin America.....III-723 $600  
   Market Analysis.....III-72
Table 64: Latin American Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-72
1$200
   Table 65: Latin America Long Term Projections for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-731$200
   Table 66: Latin American 10-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-741$200
IV. COMPETITIVE LANDSCAPE 314$995
  
Total Companies Profiled: 85 (including Divisions/Subsidiaries - 133)

Region/Country                 Players

The United States                 60
Canada                            11
Japan                             13
Europe                            42 
     France                        5
     Germany                      12
     The United Kingdom            3
     Italy                         5
     Spain                         2
     Russia                        x
     Rest of Europe               15 
Asia-Pacific (Excluding Japan)     6
Middle East                        1
Latin America                      x
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.